GEARING UP FOR WWJ 950'S THAW RADIOTHON: BID IN THE ONLINE AUCTION NOW!  

Generic Prescription Pharmaceuticals

Perrigo Gets Patent Challenge For Generic Axiron, FDA Approval For Generic Sanctura XRPerrigo Co. (Nasdaq: PRGO) announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for testosterone topical solution, the generic version of Axiron Topical Solution.
Perrigo Confirms Settlement Of Generic Version Of Ofirmev Injection Patent LitigationAllegan-based Perrigo Co. (Nasdaq: PRGO) announced that it has agreed to settle its Hatch-Waxman litigation relating to Ofirmev (acetaminophen) injection brought by Cadence Pharmaceuticals Inc.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen